---
trial_id: 993
discovery_date: 2022-06-24 12:35:36.821491
date: 2022-06-24 12:35:36.821491
title: "A Multi-center, Open-label Study to Determine the Dose and Safety of Oral Asciminib in Pediatric Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP), Previously Treated With One or More Tyrosine Kinas ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04925479'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
